| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 9.970 | 12.470 | 23.464 | 18.432 | 19.613 | 20.468 |
| Total Income - EUR | - | - | - | - | 10.042 | 26.999 | 27.841 | 22.058 | 23.820 | 21.164 |
| Total Expenses - EUR | - | - | - | - | 4.833 | 26.273 | 28.210 | 32.351 | 21.449 | 24.247 |
| Gross Profit/Loss - EUR | - | - | - | - | 5.209 | 725 | -368 | -10.294 | 2.371 | -3.083 |
| Net Profit/Loss - EUR | - | - | - | - | 5.142 | 601 | -788 | -10.478 | 1.706 | -3.096 |
| Employees | - | - | - | - | 0 | 2 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Theralandstru S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 985 | 13.913 | 15.965 | 9.410 | 3.396 | 2.032 |
| Current Assets | - | - | - | - | 32.895 | 5.483 | 4.294 | 3.674 | 4.060 | 2.574 |
| Inventories | - | - | - | - | 5.268 | 0 | 0 | 0 | 0 | 49 |
| Receivables | - | - | - | - | 8.994 | 265 | 2.059 | 3.668 | 2.821 | 2.480 |
| Cash | - | - | - | - | 18.633 | 5.219 | 2.236 | 5 | 1.239 | 45 |
| Shareholders Funds | - | - | - | - | 5.184 | 5.686 | 4.772 | -5.691 | -3.967 | -7.041 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 696 | 769 | 7.211 | 14.097 | 11.042 | 12.001 |
| Income in Advance | - | - | - | - | 28.000 | 12.941 | 8.277 | 4.678 | 700 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8130 - 8130" | |||||||||
| CAEN Financial Year |
8130
|
|||||||||
Comments - Theralandstru S.r.l.